The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA

• Status: Recruiting
• Trial end date: 2025-11-30
• Target enrollment: 0
• Participant gender: All

Summary

This interventional study aims to compare the effectiveness of local multimodal drug periarticular injection in TKA patients with the standard pain control regime that includes opioids, NSAIDs, and other analgesics.

The main questions The investigators strive to answer are:

Is there a significant difference in the severity of pain and functional outcomes when applying periarticular injections? Are there any increased complications when applying the periarticular injections?

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Damascus University
• Treatments: Acetaminophen; Bupivacaine; Epinephrine; Ketorolac; Ketorolac Tromethamine; Tramadol

Criteria

Inclusion Criteria:

• all patients with end-stage arthritis of the knee going primary unilateral total knee arthroplasty.

Exclusion Criteria:

• inflammatory and secondary arthritis of the knee.

• Patients who are allergic to one or more of the drugs used in the injections.

• Patients who are already taking opioids for whatever reason or have a history of addiction.

• BMI less than 20 and more than 35.

• patients with intra-operative complications that would affect the outcomes measurement.

• Patients who are going through complex primary or revision TKA.

• Pregnancy, renal or liver failure.

• Patients who are classified as grade 3 or more according to ASA.